Dr. James L. Wilder, MD
Gynecologic Oncology (Gynecologic Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical School at San Antonio (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 172
Licensed in Texas since 2001, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: University of Texas Medical School at San Antonio
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gynecologic Oncology Physician primary
TX license L2750 (first issued 2001; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ut of Texas Southwestern University Hospital - William P. Clements Jr. Dallas, TX
- Parkland Health & Hospital System Dallas, TX
- Texas Health Harris Methodist Fort Worth Fort Worth, TX
Medical groups
- University of Texas Southwestern Medical Center at Dallas (3,187 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 172
- Services billed
- 504
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 224 | 114 |
| Established patient office or other outpatient visit, 30-39 minutes | 107 | 38 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 44 | 11 |
| New patient office or other outpatient visit, 60-74 minutes | 42 | 42 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 25 | 25 |
| Imaging of lymph nodes during surgery | 18 | 18 |
| Complete ultrasound scan of pelvis | 17 | 17 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 14 | 12 |
| New patient office or other outpatient visit, 45-59 minutes | 12 | 12 |
| Insertion of central venous tube with port (5 years or older) | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Estradiol Other prescribers in San Antonio, TX | 33 |
| Acetaminophen-Codeine (acetaminophen with codeine) Other prescribers in San Antonio, TX | 24 |
| Gabapentin Other prescribers in San Antonio, TX | 21 |
| Lynparza (olaparib) | 17 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in San Antonio, TX | 16 |
| Progesterone (progesterone, micronized) Other prescribers in San Antonio, TX | 14 |
| Xarelto (rivaroxaban) Other prescribers in San Antonio, TX | 14 |
| Clobetasol Propionate Other prescribers in San Antonio, TX | 13 |
| Raloxifene Hcl Other prescribers in San Antonio, TX | 13 |
| Ondansetron Odt (ondansetron) Other prescribers in San Antonio, TX | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 6 payments worth $330 in total to this clinician.
| Eisai Inc. | $121 |
|---|---|
| AbbVie Inc. | $105 |
| Genmab U.S., Inc. | $39.54 |
| Sobi, Inc | $36.02 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.52 |
| Food and Beverage | $290 |
|---|---|
| Education | $39.54 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genmab U.S., Inc. Jul 29, 2025 | Education Tivdak · Oncology · in-kind | $19.77 |
| Genmab U.S., Inc. Dec 9, 2025 | Education Tivdak · Oncology · in-kind | $19.77 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.